284 related articles for article (PubMed ID: 19069235)
1. The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor.
Yang KH; Fang H; Ye JS; Gong JZ; Wang JT; Xu WF
Pharmazie; 2008 Nov; 63(11):779-83. PubMed ID: 19069235
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils.
Selvatici R; Falzarano S; Mollica A; Spisani S
Eur J Pharmacol; 2006 Mar; 534(1-3):1-11. PubMed ID: 16516193
[TBL] [Abstract][Full Text] [Related]
3. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
Daughaday CC; Mehta J; Spilberg I; Atkinson JP
J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
[TBL] [Abstract][Full Text] [Related]
4. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
[TBL] [Abstract][Full Text] [Related]
5. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
Rabiet MJ; Huet E; Boulay F
Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.
Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Paci M; Sette M; Di Nola A
Biopolymers; 1993 Mar; 33(3):437-51. PubMed ID: 8461452
[TBL] [Abstract][Full Text] [Related]
7. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN
Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080
[TBL] [Abstract][Full Text] [Related]
8. Replacement of the N alpha-blocking group in the formyl-methionyl tripeptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
Toniolo C; Crisma M; Becker EL
Farmaco; 1990 Jul; 45(7-8):921-5. PubMed ID: 2177991
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
Cavicchioni G; Fraulini A; Falzarano S; Spisani S
Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells.
Viswanathan A; Painter RG; Lanson NA; Wang G
Stem Cells; 2007 May; 25(5):1263-9. PubMed ID: 17234990
[TBL] [Abstract][Full Text] [Related]
11. N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates.
Paclet MH; Davis C; Kotsonis P; Godovac-Zimmermann J; Segal AW; Dekker LV
Biochem J; 2004 Jan; 377(Pt 2):469-77. PubMed ID: 14556648
[TBL] [Abstract][Full Text] [Related]
12. Conformational investigations on analogs of inflammation response inducing chemotactic tripeptide fMLP.
Rathore RS
Biopolymers; 2005; 80(5):651-64. PubMed ID: 15648091
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.
Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499
[TBL] [Abstract][Full Text] [Related]
14. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
[No Abstract] [Full Text] [Related]
15. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
16. [Formation of signal ATP in plasma membranes of polymorphonuclear leukocytes activated by formyl-methionyl-leucyl-phenylalanine].
Karelin AA; Globa AG; Demidova VS; Marchuk AI
Vopr Med Khim; 1986; 32(5):93-8. PubMed ID: 3776122
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
Karlsson J; Fu H; Boulay F; Dahlgren C; Hellstrand K; Movitz C
J Leukoc Biol; 2005 Sep; 78(3):762-71. PubMed ID: 15951351
[TBL] [Abstract][Full Text] [Related]
18. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells.
Su SB; Gong W; Gao JL; Shen W; Murphy PM; Oppenheim JJ; Wang JM
J Exp Med; 1999 Jan; 189(2):395-402. PubMed ID: 9892621
[TBL] [Abstract][Full Text] [Related]
19. Modifications of the amide bond at position 3 in fMLP analogs select neutrophil functions.
Spisani S; Breveglieri A; Fabbri E; Vertuani G; Rizzuti O; Cavicchioni G
Pept Res; 1996; 9(6):279-82. PubMed ID: 9048420
[TBL] [Abstract][Full Text] [Related]
20. The mechanism underlying the contractile effect of a chemotactic peptide, formyl-Met-Leu-Phe on the guinea-pig Taenia coli.
Kawata H; Hirano K; Nishimura J; Kubo C; Kanaide H
Br J Pharmacol; 2005 Jun; 145(3):353-63. PubMed ID: 15735654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
